v3.26.3
SCHEDULE OF DISAGGREGATED BY PRODUCT (Details) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Disaggregation of Revenue [Line Items]        
Total revenues $ 1,254,577 $ 590,050 $ 1,654,541 $ 600,308
Losartan Potassium Oral Suspension [Member]        
Disaggregation of Revenue [Line Items]        
Total revenues 329,783 729,747
Naloxone HCl Nasal Spray [Member]        
Disaggregation of Revenue [Line Items]        
Total revenues 924,794 924,794
Pharmaceutical Product Resale [Member]        
Disaggregation of Revenue [Line Items]        
Total revenues $ 590,050 $ 600,308